bexarotene gel — Medica
Adult T-cell leukemia/lymphoma (smoldering symptomatic subtype)
Initial criteria
- Patient has smoldering symptomatic subtype
- Medication is used as first-line therapy
- Medication is prescribed by or in consultation with an oncologist or a dermatologist
Approval duration
1 year